MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer. Cannistraci A, Hascoet P, Ali A, Mundra P, et al. Oncogene 2022 Jan 17. pii: 10.1038/s41388-022-02178.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cannistraci A, Hascoet P, Ali A, Mundra P, et al. MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer. Oncogene 2022 Jan 17. pii: 10.1038/s41388-022-02178.
PMID: 35039635